Manhattan Associates (MANH) had the best year in 2000 by a large-cap US stock in 2000, returning 452.2%.
| ASSET | YEAR | % RETURN |
|---|---|---|
Manhattan Associates (MANH) | 2000 | 452.23% |
Laboratory Corporation of America (LH) | 2000 | 377.23% |
Quest Diagnostics (DGX) | 2000 | 360.86% |
Vertex Pharmaceuticals (VRTX) | 2000 | 302.82% |
Skechers (SKX) | 2000 | 300.02% |
CoreSite Realty (COR) | 2000 | 225.8% |
EOG Resources (EOG) | 2000 | 219.44% |
Everest (EG) | 2000 | 216.03% |
Waters (WAT) | 2000 | 213.62% |
Universal Health Services (UHS) | 2000 | 209.34% |
Encompass Health (EHC) | 2000 | 207.06% |
Sun Life Financial (SLF) | 2000 | 205.34% |
SEI Investments (SEIC) | 2000 | 179.23% |
Ciena (CIEN) | 2000 | 178.37% |
Regeneron Pharmaceuticals (REGN) | 2000 | 167.42% |
Check Point Software Technologies (CHKP) | 2000 | 160.61% |
Manulife Financial (MFC) | 2000 | 159.3% |
NVR (NVR) | 2000 | 158.85% |
Revvity (RVTY) | 2000 | 153.79% |
DaVita HealthCare Partners (DVA) | 2000 | 153.7% |
Chubb (CB) | 2000 | 153.03% |
Teledyne Technologies (TDY) | 2000 | 147.06% |
MetLife (MET) | 2000 | 141.38% |
BlackRock (BLK) | 2000 | 140.86% |
Jack Henry & Associates (JKHY) | 2000 | 135.61% |
Large-cap stocks are treated as having a market cap of $10B+.
